- Home
- CATO vs VTVT Comparison
CATO vs VTVT Comparison
Compare CATO & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- VTVT
- Stock Information
- Founded
- CATO 1946
- VTVT 2015
- Country
- CATO United States
- VTVT United States
- Employees
- CATO N/A
- VTVT N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- VTVT Health Care
- Exchange
- CATO Nasdaq
- VTVT Nasdaq
- Market Cap
- CATO 57.6M
- VTVT 47.9M
- IPO Year
- CATO N/A
- VTVT 2015
- Fundamental
- Price
- CATO $4.64
- VTVT $21.03
- Analyst Decision
- CATO
- VTVT Strong Buy
- Analyst Count
- CATO 0
- VTVT 2
- Target Price
- CATO N/A
- VTVT $35.50
- AVG Volume (30 Days)
- CATO 204.6K
- VTVT 3.4K
- Earning Date
- CATO 08-21-2025
- VTVT 11-11-2025
- Dividend Yield
- CATO N/A
- VTVT N/A
- EPS Growth
- CATO N/A
- VTVT N/A
- EPS
- CATO N/A
- VTVT N/A
- Revenue
- CATO $650,830,000.00
- VTVT $17,000.00
- Revenue This Year
- CATO N/A
- VTVT N/A
- Revenue Next Year
- CATO N/A
- VTVT N/A
- P/E Ratio
- CATO N/A
- VTVT N/A
- Revenue Growth
- CATO N/A
- VTVT N/A
- 52 Week Low
- CATO $2.19
- VTVT $12.62
- 52 Week High
- CATO $6.70
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- CATO 68.86
- VTVT 75.87
- Support Level
- CATO $3.84
- VTVT $19.15
- Resistance Level
- CATO $4.73
- VTVT $21.40
- Average True Range (ATR)
- CATO 0.26
- VTVT 1.20
- MACD
- CATO -0.00
- VTVT 0.32
- Stochastic Oscillator
- CATO 73.33
- VTVT 92.81
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.